Milestone Pharmaceuticals Inc. (MIST) Earnings Call Transcripts

Milestone Pharmaceuticals Inc.'s Latest Earnings Call - June 10, 2026

In the Milestone Pharmaceuticals Inc. (MIST:US) Annual Meeting held on June 10, 2026, management reported no significant changes in revenue or earnings, as the focus was primarily on governance and shareholder proposals. The company successfully passed all proposals, including the election of directors and the amendment of the equity incentive plan. There were no financial metrics or guidance updates provided during the meeting, which may lead to investor uncertainty regarding future performance.

Reported metrics

Guidance from management

No specific financial guidance or updates were provided during the meeting, leaving future expectations unclear.

What management said

I have at this meeting a complete list of the shareholders of record of the company's common shares as of April 15, 2026, the record date for this meeting. On May 1, 2026, a notice of Internet availability of proxy materials was deposited in the Canadian Postal system to registered shareholders of record at the close of business on April 15, 2026.

At this time, I would like to introduce Steve Gilbert, a representative of Computershare Investor Services, Inc. I am appointing Mr. Gilbert to act as Inspector of Election at this meeting. Mr. Gilbert has taken and subscribed the customary oath of office to execute his duties with strict impartiality. We will file this oath with the records of the meeting. Mr. Gilbert's function is to decide upon the qualifications ...

What analysts pressed on

Analysts expressed concerns over the lack of financial updates and metrics during the meeting, which could indicate a lack of transparency or preparedness from management regarding the company's performance.

Main topics on the call

• Director Elections — All eight nominees for director were elected to serve until the close of the 2027 Annual Meeting. This includes CEO Joe Oliveto and other key members of the management team, signaling continuity in leadership.
• Appointment of Auditors — PricewaterhouseCoopers was reappointed as the independent auditor for the company until the close of the 2027 Annual Meeting. This decision reflects confidence in the current audit practices and governance structure.
• Equity Incentive Plan Amendment — The amendment to increase the number of shares authorized for issuance by 6,800,000 was approved, indicating a commitment to incentivizing employees and aligning their interests with shareholders.
• Advisory Vote on Executive Compensation — The advisory vote on the compensation of the company's named executive officers was approved, suggesting shareholder support for the current compensation strategy.

Read the full Milestone Pharmaceuticals Inc. transcript (June 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 13 Milestone Pharmaceuticals Inc. earnings call transcripts on record, spanning July 23, 2020 to June 10, 2026. Based on this history, Milestone Pharmaceuticals Inc. reports semi-annually. The most recent call on file is dated June 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MIST

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

13

First call

July 23, 2020

Most recent

June 10, 2026

Reporting cadence

semi-annually